Also known as آسٹیوپوروسس مینجمنٹ
Diabetologist
M.B.B.S, Dip. In Diabetes
Internal Medicine Specialist
MBBS, MRCP UK ( Internal Medicine), SCE UK (Endocrinology and Diabetes)
Internal Medicine Specialist
MBBS, MRCP UK ( Internal Medicine), SCE UK (Endocrinology and Diabetes)
Internal Medicine Specialist
Certified in Diabetology (USA), F.C.P.S (Medicine), M.B.B.S
Internal Medicine Specialist
Certified in Diabetology (USA), F.C.P.S (Medicine), M.B.B.S
Gastroenterologist
MBBS, FCPS (Gastroenterology), European Speciality Certificate in Gastroenterology and Hepatalogy (UK)
Gastroenterologist
MBBS, FCPS (Gastroenterology), European Speciality Certificate in Gastroenterology and Hepatalogy (UK)
Internal Medicine Specialist
MBBS, FCPS, MRCP (Ireland), MRCP (Glasgow)
Internal Medicine Specialist
MBBS, MD (Internal Medicine)
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Endocrinologist
M.B.B.S., F.C.P.S., Fellowship in Diabetes & Endocrine
Endocrinologist
M.B.B.S., F.C.P.S., Fellowship in Diabetes & Endocrine
General Physician
MBBS, FRACGP (Australia), Professional Certificate in Women Helath (Australia)
General Physician
MBBS, FRACGP (Australia), Professional Certificate in Women Helath (Australia)
Internal Medicine Specialist
M.B.B.S., F.C.P.S. (Medicine), F.C.P.S.
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures